Oral Food Challenge for Food Intolerance
(INFINITY Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to diagnose food protein-induced enterocolitis syndrome (FPIES), a condition that causes severe digestive reactions to certain foods. The researchers aim to determine the optimal dose for a low-dose, multi-day oral food challenge, which involves gradually consuming small amounts of food to observe if symptoms are triggered. Participants will test different doses of food protein, either at home (At-Home Low-Dose Oral Food Challenge) or under supervision (Supervised High-Dose Oral Food Challenge or Supervised Low-Dose Oral Food Challenge). This trial suits individuals aged 1-60 who have previously experienced an FPIES reaction and can identify symptoms like severe vomiting or diarrhea after consuming certain foods. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research in diagnosing FPIES.
Will I have to stop taking my current medications?
The trial requires participants to stop taking certain medications for 7 days before the screening visit and throughout the study, unless they are needed as rescue medications.
What prior data suggests that this protocol is safe for diagnosing FPIES?
Research has shown that oral food challenges (OFCs) are generally safe for diagnosing food allergies. An OFC involves consuming small amounts of the suspected food allergen under medical supervision to monitor for reactions. Studies have found that low-dose OFCs are particularly well-tolerated. In one study, infants under one year safely consumed small amounts of allergenic foods without severe reactions.
The supervised high-dose OFC is also considered safe, though the risk of a reaction increases with the larger amount of allergen. Medical staff are present to manage any reactions that may occur during these tests.
Overall, while reactions can occur, they are usually mild and manageable. The medical team ensures participants' safety throughout the process.12345Why are researchers excited about this trial?
Researchers are excited about the Oral Food Challenge (OFC) trial for food intolerance because it explores different approaches to manage and potentially improve food tolerance in a controlled and measured way. Unlike standard treatments that often involve strict avoidance or gradual introduction of allergens, this trial is testing various doses of food proteins to see how they can be safely reintroduced. The trial includes both at-home low-dose and supervised high-dose challenges, which could offer more flexibility and insight into personalized treatment plans for individuals with food intolerances. By examining how different doses affect tolerance, the trial may pave the way for more tailored, effective strategies to manage food intolerance, ultimately improving patient quality of life.
What evidence suggests that this trial's treatments could be effective for diagnosing food protein-induced enterocolitis syndrome?
Research has shown that oral food challenges (OFCs) reliably test for food allergies, including food protein-induced enterocolitis syndrome (FPIES). These tests diagnose food allergies by gradually introducing the suspected allergen and observing any reactions. In this trial, participants will undergo various types of OFCs. Some will take part in at-home low-dose OFCs, which studies recommend for safely diagnosing food allergies, as they provide crucial information about a person's sensitivity to certain foods. Others will participate in supervised high-dose OFCs, which are valuable for helping patients learn about and manage their food allergies. These methods enable doctors to better understand the severity and management of food allergies.14678
Who Is on the Research Team?
Anna Nowak-Wegrzyn, MD, PhD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for individuals aged 1-60 with suspected or confirmed food protein-induced enterocolitis syndrome (FPIES), a condition causing digestive distress after eating certain foods. Details on who can't join are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants complete a baseline gastrointestinal symptom diary
Low Dose Oral Food Challenge
Participants undergo a supervised Low Dose OFC to their FPIES trigger
Home Challenge
Participants who do not react at the Day 1 Low Dose OFC continue with a daily home challenge
High Dose Oral Food Challenge
Participants who tolerated the home challenges undergo a High Dose OFC
Follow-up
Participants are monitored for safety and effectiveness after the challenges
What Are the Treatments Tested in This Trial?
Interventions
- At-Home Low-Dose Oral Food Challenge
- Supervised High-Dose Oral Food Challenge
- Supervised Low-Dose Oral Food Challenge
Trial Overview
The study tests different ways to diagnose FPIES using oral food challenges: high-dose and low-dose supervised in a clinic, and low-dose at home. It aims to find the safest and most effective dose for these tests.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Participants will be sequentially enrolled into 3 cohorts of 24 each. Following interim analysis of Low Dose OFC outcomes in cohort 1, Low-Dose OFC may be continued at 300 mg food protein or be amended for cohort 2 and 3 based on pre-specified criteria.
Participants will be sequentially enrolled into 3 cohorts of 24 each. Following interim analysis of Low Dose OFC outcomes in cohort 1, Low-Dose OFC may be continued at 300 mg food protein or be amended for cohort 2 and 3 based on pre-specified criteria.
Participants will be sequentially enrolled into 3 cohorts of 24 each. The first cohort will undergo Low Dose OFC to 300 mg food protein. Following interim analysis of Low Dose OFC outcomes in cohort 1, the Low Dose OFC serving size may be amended or continued at 300 mg food protein for cohort 2 \& 3 based on pre-specified criteria.
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator
Published Research Related to This Trial
Citations
Evaluating the efficacy of a novel home-based oral food ...
Food protein–induced enterocolitis syndrome (FPIES) is a non-immunoglobulin E (IgE)-mediated food allergy, predominantly affecting infants [1].
Efficacy of very-low-dose oral food challenge in children ...
In Japan, HE allergy accounts for 39% of immediate-type food allergies, making it a predominant allergen encountered in pediatric clinical practice. The ...
Low‐dose oral food challenges - Takei - 2024
... food allergy recommends low-dose oral food challenges ... However, data regarding OFCs performed in infants aged <1 year with food allergies ...
Will Oral Food Challenges Still Be Part of Allergy Care ...
However, OFCs can also provide additional phenotypic information about the allergy, such as sensitivity to the allergen (ie, whether the patient ...
Oral Food Challenge
An oral food challenge is a highly accurate diagnostic test for food allergies. Learn about the three types and how they work.
6.
nationwidechildrens.org
nationwidechildrens.org/family-resources-education/health-wellness-and-safety-resources/helping-hands/food-allergy-oral-food-challengeFood Allergy: Oral Food Challenge
You Might Also Be Interested In. Shellfish. Blog. Food Allergy vs. Intolerance: Knowing the Difference.
Will Oral Food Challenges Still Be Part of Allergy Care in ...
However, OFCs can also provide additional phenotypic information about the allergy, such as sensitivity to the allergen (ie, whether the patient requires a ...
Oral Food Challenge (OFC): Test, Risks & Results
IgE-mediated means that IgE allergy antibodies cause the allergic reaction. These types of allergies typically produce an immediate reaction to a food. Test ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.